Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Chest MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- International Society for heart and lung transplantation. The International Thoracic organ transplant Registry of the International Society for heart and lung transplantation: Thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match.J Heart Lung Transpl. 2019 Oct; 38 (Epub 2019 Aug 8. PMID: 31548030): 1042-1055https://doi.org/10.1016/j.healun.2019.08.001
- The International Thoracic organ transplant Registry of the International Society for heart and lung transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; focus theme: Multiorgan transplantation.J Heart Lung Transpl. 2018; 37: 1169-1183
- Cognitive function, mental health, and health-related quality of life after lung transplantation.Ann Am Thorac Soc. 2014; 11: 522-530
- Antibody-mediated lung transplant rejection.Curr Respir Care Rep. 2012; 1: 157-161
- Antibody-mediated rejection in lung transplantation.Transplantation. 2014; 98: 927-930
- Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series.Transpl Immunol. 2013; 28: 1-5
- Pathologic findings in lung allografts with anti-HLA antibodies.J Heart Lung Transpl. 2013; 32: 326-332
- Acute antibody-mediated rejection after lung transplantation.J Heart Lung Transpl. 2013; 32: 1034-1040
- Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Hum Immunol. 2013; 74: 1478-1485
- Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT.J Heart Lung Transpl. 2013; 32: 14-21
- Analysis of early deaths after isolated lung transplantation.Chest. 2001; 120: 225-232
- Detection of HLA antibodies in organ transplant recipients – Triumphs and challenges of the solid phase bead assay.Front Immunol. 2016; 7: 570
- Pulmonary capillaritis: a possible histologic form of acute pulmonary allograft rejection.J Heart Lung Transpl. 1998; 17: 415-422
- Humoral (antibody-mediated) rejection in lung transplantation.J Heart Lung Transpl. 1996; 15: 1217-1222
- Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American Heart Association.Circulation. 2019; 139: e553-e578
- HLA sensitization: can it be prevented?.Pediatr Nephrol. 2015; 30: 577-587
- Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.J Heart Lung Transpl. 2014; 33: 1074-1082
- Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay.Transplantation. 2013; 95: 761-765
- The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation.Am J Transpl. 2018; 18: 936-944
- The Impact of pre-transplant allosensitization on outcomes after lung transplantation.J Heart Lung Transpl. 2015; 34: 1415-1422
- Association between allosensitization and waiting list outcomes among adult lung transplant candidates in the United States.Ann Am Thorac Soc. 2019; 16: 846-852
- Donor-specific antibodies in lung transplantation.Curr Opin Organ Transpl. 2020 Dec; 25: 563-567
- Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates.Am J Respir Crit Care Med. 2014; 189: 1234-1239
- Survival in sensitized lung transplant recipients with perioperative desensitization.Am J Transpl. 2015; 15: 417-426https://doi.org/10.1111/ajt.13076
- De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation.J Heart Lung Transpl. 2014; 33: 1288-1294
- Human leukocyte antigens antibodies after lung transplantation: primary results of the HALT study.Am J Transpl. 2018; 18: 2285-2294
- Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation.J Heart Lung Transpl. 2010; 29: 973-980
- De novo DQ donor-specific antibodies are associated with chronic lung allograft dysfunction after lung transplantation.Am J Respir Crit Care Med. 2016; 194: 596-606
- Persistence of de novo donor specific HLA-Antibodies after lung transplantation: a potential marker of decreased patient survival.HLA. 2018; 92: 24-32
- Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction.Semin Immunol. 2012 Apr; 24: 131-135
- A 3-center study Reveals New Insights into the impact of non-HLA antibodies on lung transplantation outcome.Transplantation. 2017; 101: 1215-1221
- Integrative analysis correlates donor transcripts to recipient autoantibodies in primary graft dysfunction after lung transplantation.Immunology. 2011; 132: 394-400
- Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.J Heart Lung Transpl. 2013; 32: 807-814
- Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation.Am J Transpl. 2012; 12: 2164-2171
- Antibody-mediated rejection of the lung: a consensus report of the International Society for heart and lung transplantation.J Heart Lung Transpl. 2016; 35: 397-406
- Thoracic organ transplantation: laboratory methods.Methods Mol Biol. 2013; 1034: 127-143
- On solid-phase antibody assays.J Heart Lung Transpl. 2010; 29: 1207-1209
- Assessing antibody Strength: Comparison of MFI, C1q, and titer Information.Am J Transpl. 2015; 15: 2421-2430
- Evolving experience of treating antibody-mediated rejection following lung transplantation.Transpl Immunol. 2014; 31: 75-80
- Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Am J Transpl. 2014; 14: 255-271
- HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection.J Heart Lung Transpl. 2004; 23: 1135-1141
- Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies.J Heart Lung Transpl. 2014; 33: 1223-1232
- Update on pathology of antibody-mediated rejection in the lung allograft.Curr Opin Organ Transpl. 2014; 19: 303-308
- Free airway C4d after lung transplantation - a Quantitative analysis of Bronchoalveolar Lavage Fluid.Transpl Immunol. 2020; 64: 101352
- Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.Am J Transpl. 2014; 14: 272-283
- Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Curr Opin Organ Transpl. 2014; 19: 33-40
- Molecular diagnosis of antibody-mediated rejection in human kidney transplants.Am J Transpl. 2013; 13: 971-983
- NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.Am J Transpl. 2010; 10: 1812-1822
- Presentation and outcomes of C4d-negative antibody-mediated rejection after kidney transplantation.Am J Transpl. 2016; 16: 213-220
- National conference to assess antibody-mediated rejection in solid organ transplantation.Am J Transpl. 2004; 4: 1033-1041
- Ultrastructural changes in pulmonary allografts with antibody-mediated rejection.J Heart Lung Transpl. 2020; 39: 165-175
- Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis.J Heart Lung Transpl. 2018; 37: 925-932
- Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.EBioMedicine. 2019; 40: 541-553
- Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.J Heart Lung Transplant. 2021; 40: 822-830
- Extracellular vesicles mediate immune responses to tissue-associated self-antigens: role in solid organ transplantation.Front Immunol. 2022; 13: 1-15
- The role of donor derived exosomes in lung allograft rejection.Hum Immunol. 2019; 80: 588-594
- Early effects of first-line treatment with anti-interleukin-6 receptor antibody tocilizumab for chronic active antibody-mediated rejection in kidney transplantation.Clin Transplantion. 2020; 34: e13908
- Novel therapeutic approaches to allosensitization and antibody-mediated rejection.Transplantation. 2018; 103: 262-272
- Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection.J Clin Invest. 2019; 129: 556-568
- Lung injury combined with loss of regulatory T cells leads to de novo lung-restricted autoimmunity.J Immunol. 2016; 197: 51-57
- Antibody-mediated rejection management following lung transplantation.Ann Pharmacother. 2022; 56: 60-64
Article info
Footnotes
Disclosure Statement: R.R. Hachem has received grant funding from Bristol Myers Squibb, United States and Mallinckrodt Pharmaceuticals, Canada and is a consultant for Transmedics, CareDx, and Natera. This work was funded in part by NHLBI, United States grant HL138186. L.P. Halverson has no financial relationships to disclose.
Funded by: WUSL.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
